Table 7.
Median Follow-Up of 4.4 mo by Clinical Care (n=1193) | measured GFR <60 (n=387) | measured GFR <45 (n=38) | ||
---|---|---|---|---|
OR (95% CI) | P Value | OR (95% CI) | P Value | |
Unadjusted | ||||
Nephron number, per 100,000 | 0.91 (0.89 to 0.94) | <0.0001 | 0.84 (0.76 to 0.93) | 0.0005 |
Nephron number <5th percentile | 1.54 (1.02 to 2.34) | 0.04 | 0.92 (0.28 to 3.06) | 0.90 |
Nephron number <10th percentile | 1.51 (1.08 to 2.12) | 0.02 | 1.99 (0.92 to 4.28) | 0.08 |
% GSG, per SD | 1.31 (1.17 to 1.47) | <0.0001 | 1.59 (1.32 to 1.91) | <0.0001 |
IFTA, per 5% | 4.11 (1.94 to 8.72) | 0.0002 | 1.18 (0.54 to 2.57) | 0.67 |
IFTA foci density, per SD | 1.31 (1.17 to 1.46) | <0.0001 | 1.21 (0.99 to 1.49) | 0.07 |
Adjusted for nephrosclerosis measuresb | ||||
Nephron number, per 100,000 | 0.92 (0.89 to 0.95) | <0.0001 | 0.87 (0.78 to 0.96) | 0.006 |
Nephron number <5th percentile | 1.46 (0.95 to 2.24) | 0.08 | 0.70 (0.20 to 2.50) | 0.58 |
Nephron number <10th percentile | 1.45 (1.03 to 2.05) | 0.03 | 1.62 (0.72 to 3.65) | 0.24 |
Further adjusted for glomerular volume | ||||
Nephron number, per 100,000 | 0.89 (0.86 to 0.93) | <0.0001 | 0.83 (0.75 to 0.93) | 0.001 |
Nephron number <5th percentile | 1.56 (0.99 to 2.44) | 0.05 | 0.72 (0.19 to 2.70) | 0.63 |
Nephron number <10th percentile | 1.55 (1.07 to 2.23) | 0.02 | 1.75 (0.75 to 4.11) | 0.19 |
Further adjusted for clinical characteristicsc | ||||
Nephron number, per 100,000 | 0.95 (0.91 to 0.99) | 0.02 | 0.89 (0.79 to 1.01) | 0.06 |
Nephron number <5th percentile | 1.65 (0.97 to 2.81) | 0.07 | 0.85 (0.23 to 3.12) | 0.80 |
Nephron number <10th percentile | 1.51 (0.98 to 2.32) | 0.06 | 2.06 (0.85 to 4.98) | 0.11 |
OR, odds ratio; CI, confidence interval; GSG, globally sclerotic glomerular; IFTA, interstitial fibrosis and tubular atrophy.
%GSG, %IFTA and interstitial fibrosis and tubular atrophy foci density.
Age, follow-up time, sex, and baseline GFR.